Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Insulet Co. stock logo
PODD
Insulet
$324.75
+0.8%
$264.14
$170.67
$325.22
$22.85B1.26706,707 shs836,387 shs
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Insulet Co. stock logo
PODD
Insulet
0.00%+4.62%+31.58%+15.75%+79.86%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Insulet Co. stock logo
PODD
Insulet
4.5011 of 5 stars
2.45.00.04.93.90.81.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Insulet Co. stock logo
PODD
Insulet
2.82
Moderate Buy$306.53-5.61% Downside

Current Analyst Ratings Breakdown

Latest PODD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/13/2025
Insulet Co. stock logo
PODD
Insulet
Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradePeer Perform ➝ Outperform$350.00
5/9/2025
Insulet Co. stock logo
PODD
Insulet
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$312.00 ➝ $324.00
4/30/2025
Insulet Co. stock logo
PODD
Insulet
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$234.00 ➝ $266.00
4/29/2025
Insulet Co. stock logo
PODD
Insulet
Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Peer Perform
4/28/2025
Insulet Co. stock logo
PODD
Insulet
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$322.00
3/6/2025
Insulet Co. stock logo
PODD
Insulet
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$340.00
2/21/2025
Insulet Co. stock logo
PODD
Insulet
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$310.00 ➝ $355.00
2/21/2025
Insulet Co. stock logo
PODD
Insulet
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$294.00 ➝ $328.00
2/21/2025
Insulet Co. stock logo
PODD
Insulet
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$245.00 ➝ $293.00
2/21/2025
Insulet Co. stock logo
PODD
Insulet
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$305.00 ➝ $322.00
(Data available from 5/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Insulet Co. stock logo
PODD
Insulet
$2.20B10.39$4.28 per share75.96$10.49 per share30.96
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Insulet Co. stock logo
PODD
Insulet
$206.30M$5.5656.0965.343.6220.19%24.46%8.33%N/A

Latest PODD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2025Q1 2025
Insulet Co. stock logo
PODD
Insulet
$0.81$1.02+$0.21$0.50$543.20 million$569.00 million
2/20/2025Q4 2024
Insulet Co. stock logo
PODD
Insulet
$1.00$1.15+$0.15$1.39$582.02 million$597.50 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Insulet Co. stock logo
PODD
Insulet
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Insulet Co. stock logo
PODD
Insulet
1.21
3.68
2.80

Institutional Ownership

CompanyInstitutional Ownership
Insulet Co. stock logo
PODD
Insulet
N/A

Insider Ownership

CompanyInsider Ownership
Insulet Co. stock logo
PODD
Insulet
0.39%
CompanyEmployeesShares OutstandingFree FloatOptionable
Insulet Co. stock logo
PODD
Insulet
2,60070.38 million69.82 millionOptionable

Recent News About These Companies

Insulet (NASDAQ:PODD) Stock Rating Upgraded by Wolfe Research
Outlier Money Flows Lift Insulet

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Insulet stock logo

Insulet NASDAQ:PODD

$324.75 +2.73 (+0.85%)
Closing price 05/16/2025 04:00 PM Eastern
Extended Trading
$324.74 -0.01 (0.00%)
As of 05/16/2025 07:17 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.